Literature DB >> 7855189

Differential sensitivity to the effects of albuterol on locomotor activity and operant behavior.

J M O'Donnell1.   

Abstract

The purpose of the present study was to determine the effects of the beta-2 selective adrenergic agonist albuterol on three behaviors, locomotor activity, behavior maintained under a differential-reinforcement-of-low-rate (DRL) schedule, and behavior maintained under a multiple fixed-interval, fixed-ratio (FI-FR) schedule of reinforcement. Albuterol reduced response rate under the DRL schedule in a manner that resulted in an increase in reinforcement rate. Similarly, albuterol reduced response rate under both components of the multiple FI-FR schedule in a dose-dependent manner. The ED50 values for the effects of albuterol on these two operant behaviors were calculated to be approximately 1 mg/kg and the minimal effective doses were 0.3-1 mg/kg. In addition to affecting operant behavior, albuterol also reduced locomotor activity; the ED50 values and minimal effective doses were 0.05 and 0.03 mg/kg, respectively. The effects of albuterol on DRL behavior, FI-FR behavior and locomotor activity were antagonized by the beta adrenergic antagonist propranolol; this suggests that the behavioral effects of this agonist were mediated, at least in part, by beta adrenergic receptors. The differential sensitivity of locomotor activity and operant behavior to albuterol suggests that the actions of this drug on locomotor activity may be mediated predominantly by peripheral beta adrenergic receptors and that its effects on operant behavior may be mediated by beta adrenergic receptors in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7855189     DOI: 10.1007/bf02245705

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  The action of imipramine, amitriptyline, doxepin and butriptyline in an operant conditioning schedule.

Authors:  L Molinengo; S Ricci-Gamalero
Journal:  Psychopharmacologia       Date:  1972

2.  Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man.

Authors:  L E Martin; J C Hobson; J A Page; C Harrison
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

3.  The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.

Authors:  J W McKearney
Journal:  J Pharmacol Exp Ther       Date:  1968-02       Impact factor: 4.030

4.  Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior.

Authors:  G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Interactions of flerobuterol, an antidepressant drug candidate, with beta adrenoceptors in the rat brain.

Authors:  R Zini; D Morin; P Martin; A J Puech; J P Tillement
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

6.  A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study.

Authors:  Y Lecrubier; A J Puech; R Jouvent; P Simon; D Widlocher
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

7.  A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine.

Authors:  K T Finnegan; M M Terwilliger; P A Berger; L E Hollister; J G Csernansky
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

8.  Effects of centrally acting beta adrenergic agonists on discrete trial conditioned avoidance behavior in rats.

Authors:  J F McElroy; J J Stimmel; J M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Differential effects of imipramine in rats as a function of DRL schedule value.

Authors:  P S McGuire; L S Seiden
Journal:  Pharmacol Biochem Behav       Date:  1980-11       Impact factor: 3.533

10.  Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.

Authors:  J F McElroy; J M O'Donnell
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

View more
  4 in total

1.  Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats.

Authors:  Han-Ting Zhang; Ying Huang; James M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2003-07-25       Impact factor: 4.530

2.  Estradiol impairs response inhibition in young and middle-aged, but not old rats.

Authors:  Victor C Wang; Steven L Neese; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2011-01-28       Impact factor: 3.763

3.  Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors.

Authors:  K D Murugaiah; J M O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

4.  Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.

Authors:  Nazanin Ghazanfari; Marco Morsch; Nigel Tse; Stephen W Reddel; William D Phillips
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.